TARA BOZEK: Open Payments
NPI 1144751892 · UNIONTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,319 in 67 payments from 18 companies in 2025. Trend: 2023 $1,210 · 2024 $1,514 · 2025 $1,319
Food & beverage: $1,319
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $326 |
| PFIZER INC. | 16 | $225 |
| Novo Nordisk Inc | 13 | $212 |
| GlaxoSmithKline, LLC. | 10 | $158 |
| Merck Sharp & Dohme LLC | 4 | $79 |
| ABBVIE INC. | 4 | $66 |
| Abbott Laboratories | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Amgen Inc. | 2 | $32 |
| Lundbeck LLC | 1 | $23 |
Products named: BREZTRI, TRELEGY ELLIPTA, GARDASIL 9, Wegovy, ELIQUIS, CREON, PREVNAR 20, FARXIGA.
Industry payments across PA — which companies pay providers there.
